Answers - Legal

Real Estate, by its own very nature, is all black and white - you either do things, or you don't.

There is no grey area in Real Estate, which one can find otherwise

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

in commerce and trade. For instance, letter of intents that are widely used prior and during negotiations between corporations or between individuals and corporations have no place wh

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

tsoever in the world of real estate, where the only subject matter of trade is the exchange of titled interests in land for money. One cannot stipulate today to contract out in the fu

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ture and hope the stipulation will be upheld, unless such an agreement is contained in a contract drafted and accepted today and is in the form of an option.

In essence, a stipulatio

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

to contract out at a later date is a void contract, meaning that such a stipulation does not exist under the law of real estate because no contract ever existed in the first p

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

lace. Therefore the parties to the stipulation must be returned to their original bargaining positions as far as it is practically possible. This is also the case in the situation whe

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

e both parties want the stipulation to continue - an impossibility since no contract exists between them in the present tense.

This principle was recently reaffirmed in the Supreme C

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ourt of British Columbia in a case involving a private transaction between a prospective Purchaser and a prospective Seller. In this case there was a document executed between the par

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ies, which clearly set out the legal description of the real property to be exchanged as well as the purchase price - CAD 580,000. The document also set out that there would be a depo

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

sit of $10,000 held by the purchaser's lawyer in trust, that the deposit would be applied towards the purchase price and that it would be returned to the purchaser if the sale failed

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

o complete.

Although on a cursory examination this document closely resembled a Contract Of Purchase And Sale there was, however, a fundamental element entirely missing: the date of

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ompletion. As no completion date had yet been agreed upon, a paragraph was inserted in its lieu that read as follows:

"The Contract of Purchase and Sale of the Property will be p

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

repared by the Purchaser's lawyers with terms & conditions, and the date of completion of the Property to be agreed by the Vendor and the Purchaser".

Later on a completion date

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

as actually agreed upon by the parties, stipulated to be March 3, 2005. On February 24, the solicitor for the Purchaser forwarded to the solicitor for the Vendor the necessary documen

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ts to complete the transfer. However, on March 3, 2003, the completion date set out in the document, the vendor declined to complete, on the grounds that there was only an agreement t

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

agree in the future to the purchase and sale of the subject property.

The Court agreed with the Vendor. In reaching his conclusion, the Trial Judge opined as follows:

"Here the

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

wording of the executed document is clear. The parties have said that a contract will be prepared with terms and conditions to be agreed by the vendor and the purchaser. "To be agree

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

" means some further agreement is necessary in the future. [...] this is a circumstance where "the execution of the further contract is a condition or term of the bargain".

In o

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ther words, where the parties have stated that the terms and conditions are to be agreed, it cannot be said that the document is the mere expression of the desire of the parties as to

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

the manner in which the transaction already agreed to will in fact go through.

The deposit was ordered reimbursed to the Purchaser forthwith.

Luigi Frascati

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Answers - A Contract To Enter Into A Contract Is Unenforceable

Related Articles: